{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T10:23:33Z","timestamp":1780482213283,"version":"3.54.1"},"reference-count":65,"publisher":"Informa UK Limited","issue":"8","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Drug Development and Industrial Pharmacy"],"published-print":{"date-parts":[[2018,8,3]]},"DOI":"10.1080\/03639045.2018.1445263","type":"journal-article","created":{"date-parts":[[2018,2,27]],"date-time":"2018-02-27T03:45:26Z","timestamp":1519703126000},"page":"1285-1294","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":6,"title":["Optimization of rhein-loaded polymeric nanoparticles using a factorial design and evaluation of the cytotoxic and anti-inflammatory effects"],"prefix":"10.1080","volume":"44","author":[{"given":"Carolina","family":"G\u00f3mez-Gaete","sequence":"first","affiliation":[{"name":",","place":["Chile"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Ferreira","sequence":"additional","affiliation":[{"name":",","place":["Chile"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Bustos","sequence":"additional","affiliation":[{"name":",","place":["Chile"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigrid","family":"Mennickent","sequence":"additional","affiliation":[{"name":",","place":["Chile"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Castillo","sequence":"additional","affiliation":[{"name":",","place":["Chile"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catalina","family":"Ch\u00e1vez","sequence":"additional","affiliation":[{"name":",","place":["Chile"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Novoa","sequence":"additional","affiliation":[{"name":",","place":["Chile"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Godoy","sequence":"additional","affiliation":[{"name":",","place":["Chile"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2018,3,8]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.proghi.2006.02.003"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0090633"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.23177"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204763"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.9778\/cmajo.20150018"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203355"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ket222"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2017.02.791"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.21258"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2006.01.018"},{"key":"e_1_3_3_12_1","unstructured":"National Collaborating Centre for Chronic Conditions (UK). Osteoarthritis: National Clinical Guideline for care and management in adults. NICE Clinical Guidelines No. 59. London (UK): Royal College of Physicians; 2008."},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-202745"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.062091"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X09359104"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2007.02.021"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2009.10.006"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199835050-00002"},{"key":"e_1_3_3_19_1","unstructured":"Nota informativa. Diacere\u00edna: Restricciones de uso tras la reexaminaci\u00f3n de la informaci\u00f3n. Comit\u00e9 para la Evaluaci\u00f3n de Riesgos en Farmacovigilancia europeo-PRAC. Agencia espa\u00f1ola de medicamentos y productos sanitarios AEMPS Ministerio de Sanidad servicios sociales e igualdad. 7 de marzo 2014 p. 1-2. Available from: https:\/\/www.aemps.gob.es\/informa\/notasInformativas\/medicamentosUsoHumano\/seguridad\/2014\/NI-MUH_FV_03-2014-diacereina.htm"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2005.05.003"},{"key":"e_1_3_3_21_1","first-page":"7","article-title":"Nanoparti\u00b4culas polime\u00b4ricas: tecnologi\u00b4a y aplicaciones farmace\u00b4uticas","volume":"7","author":"Go\u00b4mez-Gaete C.","year":"2014","unstructured":"Go\u00b4mez-Gaete C. Nanoparti\u00b4culas polime\u00b4ricas: tecnologi\u00b4a y aplicaciones farmace\u00b4uticas. Sociedad Farmacologi\u00b4a Chile. 2014;7:7\u201316.","journal-title":"Sociedad Farmacologi\u00b4a Chile"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2008.08.009"},{"key":"e_1_3_3_23_1","first-page":"178","article-title":"Alternatives to in vivo studies in toxicology","volume":"1","author":"Shayne G.","year":"1999","unstructured":"Shayne G. Alternatives to in vivo studies in toxicology. General Appl Toxicol. 1999;1:178\u2013182.","journal-title":"General Appl Toxicol"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2009.05.010"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2016.10.010"},{"key":"e_1_3_3_26_1","first-page":"51015","article-title":"PLGA nanoparticles formed by single- or double-emulsion with vitamin E-TPGS","volume":"82","author":"McCall RL","year":"2013","unstructured":"McCall RL, Sirianni RW. PLGA nanoparticles formed by single- or double-emulsion with vitamin E-TPGS. J Vis Exp. 2013;82:51015.","journal-title":"J Vis Exp"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/0378-5173(89)90281-0"},{"key":"e_1_3_3_28_1","unstructured":"Ch\u00e1vez C. Nueva estrategia para el tratamiento de la inflamaci\u00f3n: microencasulaci\u00f3n de rhein. Concepci\u00f3n (Chile): Universidad de Concepci\u00f3n; 2014."},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2008.07.018"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.2147\/NSA.S32837"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2008.01.013"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1369-7021(09)70164-6"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2007.08.034"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2003.08.069"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2008.12.017"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/jor.1100120219"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-004-1273-1"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1014260513728"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/nmat2116"},{"key":"e_1_3_3_40_1","first-page":"63","volume-title":"Zeta potential measurement","author":"Clogston JD","year":"2011","unstructured":"JD, Clogston AK. Patri. Zeta potential measurement. Totowa (NJ): Humana Press; 2011. p. 63\u201370."},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2007.03.012"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2010.05.027"},{"key":"e_1_3_3_43_1","volume-title":"Biomaterials science: an introduction to materials in medicine","author":"Ratner B","year":"2004","unstructured":"Ratner B, Hoffman A, Schoen F, et\u00a0al. Biomaterials science: an introduction to materials in medicine. 2nd ed. San Diego (CA): Elsevier Academic Press; 2004.","edition":"2"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2007.07.029"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2004.07.050"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-010-0152-4"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-3659(97)00113-2"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfa.2010.08.050"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2008.02.008"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2004.12.001"},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics4010001"},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2011.07.037"},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2014.04.001"},{"key":"e_1_3_3_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vph.2010.03.002"},{"key":"e_1_3_3_55_1","doi-asserted-by":"publisher","DOI":"10.1053\/joca.1999.0289"},{"key":"e_1_3_3_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-2952(02)01485-5"},{"key":"e_1_3_3_57_1","doi-asserted-by":"publisher","DOI":"10.1053\/joca.1998.0201"},{"key":"e_1_3_3_58_1","first-page":"753","article-title":"In vitro effects of diacerhein and rhein on interleukin 1 and tumor necrosis factor-alpha systems in human osteoarthritic synovium and chondrocytes","volume":"25","author":"Martel-Pelletier J","year":"1998","unstructured":"Martel-Pelletier J, Mineau F, Jolicoeur FC, et\u00a0al. In vitro effects of diacerhein and rhein on interleukin 1 and tumor necrosis factor-alpha systems in human osteoarthritic synovium and chondrocytes. J Rheumatol. 1998;25:753\u2013762.","journal-title":"J Rheumatol"},{"key":"e_1_3_3_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(02)01898-8"},{"key":"e_1_3_3_60_1","first-page":"546","article-title":"Rhein, a diacerhein-derived metabolite, modulates the expression of matrix degrading enzymes and the cell proliferation of articular chondrocytes by inhibiting ERK and JNK-ap-1 dependent pathways","volume":"25","author":"Legendre F","year":"2007","unstructured":"Legendre F, Bogdanowicz P, Martin G, et\u00a0al. Rhein, a diacerhein-derived metabolite, modulates the expression of matrix degrading enzymes and the cell proliferation of articular chondrocytes by inhibiting ERK and JNK-ap-1 dependent pathways. Clin Exp Rheumatol. 2007;25:546\u2013555.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_3_61_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1025040631514"},{"key":"e_1_3_3_62_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar2444"},{"key":"e_1_3_3_63_1","first-page":"577","article-title":"Inhibition of interleukin-1beta-induced activation of MEK\/ERK pathway and DNA binding of NF-kappaB and AP-1: potential mechanism for diacerein effects in osteoarthritis","volume":"43","author":"Domagala F","year":"2006","unstructured":"Domagala F, Martin G, Bogdanowicz P, et\u00a0al. Inhibition of interleukin-1beta-induced activation of MEK\/ERK pathway and DNA binding of NF-kappaB and AP-1: potential mechanism for diacerein effects in osteoarthritis. Biorheology. 2006;43:577\u2013587.","journal-title":"Biorheology"},{"key":"e_1_3_3_64_1","doi-asserted-by":"publisher","DOI":"10.1684\/ecn.2014.0353"},{"key":"e_1_3_3_65_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2172-10-52"},{"key":"e_1_3_3_66_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1633"}],"container-title":["Drug Development and Industrial Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/03639045.2018.1445263","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T09:58:58Z","timestamp":1770890338000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/03639045.2018.1445263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,8]]},"references-count":65,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8,3]]}},"alternative-id":["10.1080\/03639045.2018.1445263"],"URL":"https:\/\/doi.org\/10.1080\/03639045.2018.1445263","relation":{},"ISSN":["0363-9045","1520-5762"],"issn-type":[{"value":"0363-9045","type":"print"},{"value":"1520-5762","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,8]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iddi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iddi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2017-12-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-01-19","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-02-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-03-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}